Her parents were supportive and hired an instructor. In November 2023, after hundreds of hours of training and after ...
Zanubrutinib shows sustained efficacy and safety in relapsed/refractory CLL, with a median progression-free survival of 52.5 months in long-term follow-up.
Zanubrutinib and venetoclax combination shows an 87% 36-month PFS rate in CLL/SLL patients, regardless of del (17p)/TP53 or IGHV status. The SEQUOIA trial demonstrates durable minimal residual disease ...
Among patients who were newly diagnosed with multiple myeloma, Kyprolis (carfilzomib) plus Revlimid (lenalidomide) and dexamethasone (KRd) was associated with improvements in progression-free survival ...
KRd significantly prolonged progression-free survival and improved the MRD negativity rate compared to VRd in newly diagnosed multiple myeloma.
THE Guyana Digital School, officially launched on Friday at the Arthur Chung Conference Centre, has already registered 20,368 ...
A growing contingent of public school parents say school-mandated iPads, particularly in elementary and middle schools, are ...
In addition to meeting the primary endpoint of non-inferiority for overall response rate (ORR) in the BRUIN CLL-314 study, pirtobrutinib achieved a ...
Physician and science communicator Kristen Panthagani talks about why public trust in vaccines has fallen since the COVID-19 ...
Greece rolls out free obesity treatments and major preventive screening programs aimed at improving public health outcomes.
1d
Crunchyroll is ending its free anime streaming in just a few weeks, so upgrade while you still can
The current Crunchyroll memberships, as of writing, include Fan, Mega Fan, and Ultimate Fan.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback